Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Head and Neck Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Breast Neoplasms 2Zollinger-Ellison Syndrome 1Uterine Cervical Dysplasia 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Obesity 1Mouth Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Lymphocytic, Chronic, B-Cell 1Inflammation 1Gastrinoma 1Colorectal Neoplasms 1Chemotherapy Effect 1Burkitt Lymphoma 1

Interventions

Papillomavirus Vaccines 2Imiquimod 2GX-188 vaccine 2Celecoxib 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2poly(gamma-glutamic acid) 1pembrolizumab 1nimotuzumab 1epigallocatechin gallate 1artesunic acid 1artemisinin 1Sutures 1Progesterone 1Pemetrexed 1Omeprazole 1Ointments 1Ocoxin 1Nelfinavir 1Lighting 1Indomethacin 1IRX 2 1Hepatitis B Vaccines 1Geritol 1GPI0100 1Folic Acid 1Eflornithine 1Cyclophosphamide 1Conization 1Cisplatin 1Chemoprevention 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Uterine Cervical Dysplasia × Omeprazole × Clear all
NCT03267680 2025-04-13

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

University of Southern California

Phase 2 Terminated
10 enrolled 19 charts
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡